935
Views
34
CrossRef citations to date
0
Altmetric
Original Research

Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects

, &
Pages 663-671 | Published online: 16 Apr 2012

Bibliography

  • Yigit H, Queenan AM, Anderson GJ, Novel cabapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45:1151-61
  • Gupta N, Limbago BM, Patel JB, Carbapenem-resistance Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53:60-7
  • Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007;20:440-58
  • Nordmann P, Poirel L. Emerging cabapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002;8:321-31
  • Giani T, D'Andrea MM, Pecile P, Emergency in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 Carbapenemase. J Clin Microbiol 2009;47:3793-4
  • Bogaerts P, Montesinos I, Rodrigues-Villalobos H, Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing KPC-2 carbapenemase in Belgium. J Antimicrob Chemother 2010;65:361-76
  • Navon-Venezia S, Chmelnitsky I, Leavitt A, Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 2006;50:3098-101
  • Kochar S, Sheard T, Sharma R, Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009;30:447-52
  • Mammina C, Palma DM, Bonura C, Outbreak of infection with Klebsiella pneumoniae sequence type 258 producing Klebsiella pneumoniae carbapenemase 3 in intensive care unit in Italy. J Clin Microbiol 2010;48:1506-7
  • Endimiani A, DePasquale JM, Forero S, Emergence of blakpc-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J Antimicrob Chemother 2009;64:1102-10
  • Poulou A, Spanakis N, Pournaras S, Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase. J Antimicrob Chemother 2010;65:2538-42
  • Wei ZQ, Du XX, Yu YS, Plasmid-mediad KPC-2 in Klebsiella pneumoniae isolad from China. Antimicrob Agents Chemother 2007;51:763-5
  • Leavitt A, Navon-Venezia S, Chmelnitsky I, Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella penumoniae strains in an Israeli Hospital. Antimicrob Agents Chemother 2007;51:3026-9
  • Nass T, Nordmann P, Vedel G, Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother 2005;49:4423-4
  • Woodford N, Zhang J, Warner M, Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother 2008;62:1261-4
  • Hammerum AM, Hansen F, Lester C, Detection of the first two Klebsiella pneumoniae isolates with sequence type 258 producing KPC-2 carbapenemase in Denmark. Int J Antimicrob Agents 2010;35:610-12
  • Carbonne A, Thiolet JM, Fournier S, Control of a multi-hospital outbreak of KCP-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill 2010;15(48):pii=19734- Available from: http://www.eurosurveillance.org/viewArticle.aspx?articleld=19734 [ [Accessed 1 March 2011]
  • Peirano G, Seki LM, Passos VLV, Carbapenem-hidrolysind beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil. J Antimicrob Chemother 2009;63:265-8
  • Villegas MV, Lolans K, Correa A, First detection of plamid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 2006;50:2880-2
  • Pillai DR, Melano R, Rawte P, Klebsiella pneumoniae carbapenemase, Canada. Emerg Infect Dis 2009;5:827-9
  • Adler A, Navon-Venezia S, Moran-Gilard J, Laboratory and clinical evaluation of screening agar plates for the detection of carbapenem-resistant enterobacteriaceae from surveillance rectal swabs. J Clin Microbiol 2011;49(6):2239-2
  • CDC. Centers for Disease Control and Prevention. Laboratory Protocol for Detection of Carbapenem-Resistant or Carbapenemase-Producing, Klebsiella spp. And E. coli from Rectal Swabs 2009 [Internet site]. Available from: http://www.ndhealth.gov/microlab/Uploads/Lab_Protocol_KPC.pdf [Accessed March 28 2011]
  • Landman D, Salvani JK, Bratu S, Evaluation of techniques for detection of carbapenem-resistent Klebsiella penumoniae in stool surveillance cultures. J Clin Microbiol 2005;43(11):5639-41
  • CDC. Centers for Disease Control and Prevention. Modified hodge test for carbapenemase detection in Enterobacteriaceae 2009 [Internet site]. Available from: http://www.ndhealth.gov/microlab/Uploads/HodgeTest.pdf. Accessed March 28 2011
  • Tsakris A, Krista I, Poulou A, Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory. J Clin Microbiol 2009;47:362-7
  • Kitchel B, Rasheed JK, Patel JB, Molecular epidemiology of (KPC)-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009;53:3365-70
  • Gootz TD, Lescoe MK, Dib-Haij F, Genetic organization of transponase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolate in a New York City Hospital. Antimicrob Agents Chemother 2009;53:1998-2004
  • Wolter DJ, Kurpiel PM, Woodford N, Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4. Antimicrob Agents Chemoter 2009;53:557-62
  • Curiaou T, Morosini MI, Ruiz-Garbajosa P, Emergence of blakpc3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. J Antimicrob Chemother 2010;65:1608-14
  • Naas T, Cuzon G, Villegas MV, Genetic structures at the origen of acquisition of the beta-lactamase blakpc gene. Antimicrob Agents Chemoter 2008;52:1257-63
  • Le J, Castanheira M, Burgess DS, Clonal dissemination of Klebsiella pneumoniae carbapenemase KPC-3 in Long Beach, California. J Clin Microbiol 2010;48:623-5
  • Goldfarb D, Harvey SB, Jessamine K, Detection of plasmid-mediated (KPC)-producing Klebsiella pneumoniae in Otawa, Canada: evidence of intrahospital transmission. J Clin Microbiol 2009;47:1920-2
  • Roche C, Cotter M. O´Connell N, et al. First identification of class A carbapenemase-producing Klebsiella pneumoniae in the Republic of Ireland. Euro Surveill 2009;14(13):pii=19163- Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19163
  • Gasink LB, Edelstein PH, Lautenbach E, Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 2009;30:1180-5
  • Pournaras S, Krista I, Vrioni G, Characteristics of meropenem heteroresistance in Klebsiella pneumoniae KPC-producing clinical isolates of K. pneumoniae. J Clin Microbiol 2010;48:2601-4
  • Landman D, Bratu S, Quale J. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J Med Microbiol 2009;58:1303-8
  • Pournaras S, Protonotariou E, Voulgari E, Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemoter 2009;64:348-52
  • Souli M, Galani I, Antoniadou A, An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology and outcomes. Clin Infect Dis 2010;50:364-73
  • Fontana C, Favaro M, Sarmati L, Emergence of (KPC)-producing Klebsiella pneumoniae in Italy. BMC Res Notes 2010;3:40
  • Hirsch EB, Tam VH. Detection and treatment options for Klebsiella peneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 2010;65:1119-25
  • Livermore DM, Warner M, Mushtaq S, What remains against carbapenem-reistent Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, termocillin and tigecycline. Int J Antimicrob Chem 2011;37:415-19
  • Patel G, Huprikar S, Factor SH, Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099-106
  • Clinical and Laboratory Standards institute. CLSI M100-S20 (2010) Cephalosporins and Aztreonam breakpoint revisions Fact Sheet. Available from: http://www.clsi.org/Content/NavigationMenu/Committees/Microbiology/AST/CephalosporinandAztreonamBreakpointRevisionFactSheet/CephalosporinAztreonamBreakpointFactSheet.pdf [Accessed 15 March 2012]
  • Schwaber MJ, Lev B, Israeli A, Containment of a country-wide outbreak of carbapenem-resistant Kleibsiella peneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848-55
  • Bilavsky E, Schwaber MJ, Carmeli Y. How to stem the tide of carbapenemase-producing Enterobacteriaceae? Proactive versus reactive strategies. Current Opin Infect Dis 2010;23:327-31
  • Mendes RE, Bell JM, Turnidge JD, Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of conjugative plasmid (blakpc-2 plus qnrB4) and blaIMP-4 gene. Antimicrob Agents Chemother 2008;52:789-99
  • Wendt C, Schutt S, Dalpke AH, First outbreak of Klebsiella pneumoniae KPC-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 2010;29:563-70

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.